Irisin, stimulated by exercise, activates peroxisome proliferator activated receptor α signaling and is pivotal in fatty acid β-oxidation in the liver, resulting in improvements in hepatic steatosis and insulin sensitivity accompanied by the upregulation of fibroblast growth factor 21 (36, 37). Here, FNDC5 is linked to fatty liver disease.